Method for obtaining ricin/rca-free castor-oil plant seeds, ricin/rca-free castor-oil plants, method for identifying ricin/rca-free castor-oil plants, polynucleotides, constructs and uses thereof

ABSTRACT

This invention relates to a method for obtaining castor-oil plants deprived of the ricin/RCA protein, through the insertion of gene constructs into plant cells, particularly castor-oil plant ones, with the consequent production of ricin/RCA-free castor-oil plant seeds. An aspect of the invention consists in providing castor-oil plants and parts thereof containing said gene construct. The method disclosed herein appeared to be efficient to the generation of castor-oil plants deprived of ricin protein or showing low expression levels of this protein, thus allowing the use of the seed thereof to the production of detoxified cakes, both for animal nutrition and for fertilizers, not to mention its possible production in countries that set restrictions to this substance, due to ricin toxicity. Therefore, this invention also provides a method and a kit to the identification of transformed plants containing the gene constructs disclosed herein.

FIELD OF INVENTION

This invention relates to the field of plant biotechnology and molecular biology. More specifically, this invention relates to a method for obtaining castor-oil plants deprived of the ricin/RCA protein, through the insertion of gene constructs into plant cells, particularly castor-oil plant ones, with the consequent production of ricin/RCA-free castor-oil plant seeds. Another aspect of the invention refers to obtaining castor-oil plants and parts thereof containing said gene construct. Additionally, this invention provides methods for identifying the plant so transformed, such as identification kit for transformed plants.

DESCRIPTION OF THE STATE OF ART

Castor-oil plant (Ricinus communis) is an oil plant from the Euphorbiaceae family, distributed worldwide, but mostly cultivated in tropical and subtropical regions. The most relevant product from this culture is the castor oil, that corresponds to 45-55% of the seed weight. Among the major industrial applications of the castor oil and derivatives thereof, there appear the manufacture of nylon, the production of synthetic resins and fibers, plastics, oil products and artificial leather (Grand View Research, 2016. Castor Oil And Derivatives Market Analysis By Product (Sebacic Acid, Ricinoleic Acid, Undecylenic Acid, Castor Wax, Dehydrated Castor Oil), By Application (Lubricants, Surface Coatings, Biodiesel, Cosmetics & Pharmaceuticals, Plastics& Resins) And Segment Forecasts To 2024.—recovered on Jun. 13, 2018 from https://www.grandviewresearch.com/industry-analysis/castor-oil-derivatives-industry). Castor oil can be also used in the synthesis of renewable monomers and polymers, in the production of soaps, waxs, lubricants, hydraulic fluids (including brake fluids); in the production of coatings and inks, and in the cosmetic, pharmaceutical and food industries (Grand View Research (2016) Castor Oil And Derivatives Market Analysis By Product (Sebacic Acid, Ricinoleic Acid, Undecylenic Acid, Castor Wax, Dehydrated Castor Oil), By Application (Lubricants, Surface Coatings, Biodiesel, Cosmetics & Pharmaceuticals, Plastics& Resins) And Segment Forecasts To 2024—recovered on Jun. 13, 2018 from https://www.grandviewresearch.com/industry-analysis/castor-oil-derivatives-industry). In the cosmetic and perfumery sector, the castor oil is used as emollient, while, in the food industry, it is used as releasing and antiadherent agent for sweeties (FDA, 1984); in the pharmaceutical industry, the castor oil, in addition to its laxative properties, is used as drug delivery vehicle, and as excipient and additive.

Upon extraction of the oil from the castor oil seed, there remains the cake, namely the most important by-product from the culture. The castor oil cake can be used as fertilizer, both for the conventional and the organic agriculture (MELLO, Gabriel Alves Botelho de et al. Organic cultivation of onion under castor cake fertilization and irrigation depths. Acta Sci., Agron., Maringá, v. 40, e34993, 2018. Epub Feb. 5, 2018. http://dx.doi.org/10.4025/actasciagron.v40i1.34993), as it is a significant source of nitrogen, phosphorous, potassium and micronutrients (Lima, R. L. S., Severino, L. S., Sampaio, L. R., Sofiatti, V., Gomes, J. A., Beltrão, N. E. M., 2011. Blends of castor meal and castor husks for optimized use as organic fertilizer. Ind. Crops Prod. 33, 364-368).

The use of castor cake in animal nutrition is prevented by its high toxicity, primarily resulting from the presence of ricin (RCA60), a highly toxic protein, but with low potential for hemagglutination. Moreover, other low toxic components are present, such ricinine, CB-1A complex and RCA120 (Severino L S, 2005. O que sabemos sobre a torta de mamona. Documentos, 134. Embrapa Algodão, Campina Grande, P B; Barnes D J, Baldwin B S, Braasch D A, 2009. Ricin accumulation and degradation during castor seed development and late germination. Ind Crops Prod 30:254-258; Bozza W P, Tolleson W H, Rosado L A R, Zhanga B, 2015. Ricin detection: Tracking active toxin. Biotechnol Adv 33:117-123). The presence of ricin may lead to the inactivation of ribosomes, cell organelles, being potentially lethal to animals, including human beings. The lethal doses for animals range from 0.1 g/kg for equines to 2.3 g/kg for swines (FONSECA; SOTO-BLANCO. Toxicity of ricin presente in castor bean seeds Semina: Ciências Agrárias, Londrina, v. 35, n. 3, p. 1415-1424. 2014). For humans, the consumption of five seeds can be lethal (OSNES, S. The history of ricin, abrin and related toxins. Toxicon, v. 44, n. 4, p. 361-370, 2004). The use of the cake as animal food requires its prior detoxification; however, the methods developed so far are poorly efficient and/or economically unfeasible in large scale (Severino L S, Auld D L, Baldanzi M, Cândido M J D, Chen G, Crosby W, Tan D, He X, Lakshmamma P, Lavanya C, Machado O L T, Mielke T, Milani M, Miller T D, Morris J B, Morse S A, Navas A A, Soares D J, Sofiatti V, Wang M L, Zanotto M D, Zieler H (2012) A review on the challenges for increased production of castor. Agron J 104:853-880.).

As to the patent documents relating to the development of castor-oil plants without ricin, the scarce disclosures on the matter do not address obtaining castor-oil plants without ricin through molecular biology techniques. The documents from this field report an improved production of ricinucleic acid, as appears in the patent document WO200070052, that refers to a gene isolate from genomic of Ricinus communis encoding a protein able to interact with the enzyme oleate 12-hydroxylase. Nevertheless, as we assess patent documents aimed at obtaining detoxified castor-oil plants, we identify additional available technologies, as it is the case with detoxification processes of castor-oil seeds and cake (BR102015030887, CN103766598, CN103766599, CN103892145 and FR2940804).

As it is well known, there are several copies of the ricin gene inside the castor-oil plant genome (Chan A P, Crabtree J, Zhao Q, Lorenzi H, Orvis J, Puiu D, Melake-Berhan A, Jones K M, Redman J, Chen G, Cahoon E B, Gedil M, Stanke M, Haas B J, Wortman J R, Fraser-Liggett C M, Ravel J, Rabinowicz P D (2010) Draft genome sequence of the oilseed species Ricinus communis. Nat Biotechnol 28:951-956) and the amount of ricin depends on the variety (Baldoni A B, Araújo A C G, Carvalho M H, Gomes A C M M, Aragão FJL (2010) Immunolocalization of ricin accumulation during castor bean (Ricinus communis L.) seed development. Int J Plant Biol 1:61-65.); but there is no report about the existence of ricin-free plant varieties.

The post-transcriptional gene silencing refers to the transactivation of homologous genes due to RNA degradation. Although some works disclose the PTGS induction through single-copy inserts, the presence of inverted repetitions and multiple copies of transgenes is typically associated with silencing (as mentioned in the patent application US20030135888, Jorgensen et al., Plant Mol. Biol., 31:957 (1996)). The ectopic pairing DNA-DNA or DNA-RNA, or the formation of anti-sense transcriptions giving rise to dsRNA is believed to result into formation of RNA aberrant transcriptions (including the loss of RNA polyadenylation or short RNA polyadenylation, generally resulting from incomplete transcription) that activate silencing (as mentioned in the patent application US20030135888, Baulcombe et al. Curr. Opin. Biotechnol., 7:173 (1996); Depicker et al., Curr. Opin. Cell Biol., 9:373 (1997); Metzlaff et al., Cell, 88:845 (1997); Montgomery et al., Trends Genet., 14:255 (1998); Que et al., Dev. Genet., 22:110 (1998); Stam et al., Mol Cell Biol., 18: 6165 (1998); and Wassenegger et al., Plant Mol. Biol., 37:349 (1998)). The simplest PTGS method with dsRNA involves a construct containing a nucleic acid sequence, or fragment thereof, that is oriented towards the promoter in a contrary sense, thus resulting into the formation of an anti-sense mRNA. This anti-sense mRNA, upon transcription inside the organism cell, shall complementarily bind to an endogenous mRNA molecule, thus leading to the formation of a double stranded mRNA molecule, that shall trigger a process involving various enzymes to the amplification of the response, with a consequent silencing of the mRNA-specific gene, or, in other words, a reduction or lack of the protein encoding such gene (U.S. Pat. No. 5,107,065, US20030135888, US20040216190).

A derived form of anti-sense technology consists in the insertion of gene constructs inside organisms containing nucleic acid sequences in both sense and anti-sense orientations separated by a spacing sequence, such as introns, that shall lead to the formation of a structure in the shape of artificial clip of double stranded mRNA. This technology, also referred to as RNA interference, was found to be much more efficient than the mere insertion of the nucleic acid molecule in anti-sense orientation, as the mRNA molecule does not need to find the complementary molecule. The use of RNA interference (RNAi) demonstrated the possibility of obtaining plants with indetectable levels of transcription, or with no level at all (Wesley S V, Heliwell C A, Smith N A, Wang M, Rouse D T, Liu Q, Gooding P S, Singh S P, Abbott D, Stoutjesdijk P A, Robinson S P, Cleave A P, Green A G & Waterhouse P M (2001) Construct design for efficient, effective and high-throughput gene silencing in plants, The Plant Journal. 27: 581-590, WO9953050, US20030175783, US20030180945, US20050120415), and thus appears as an efficient methodology for silencing ricin in plants.

Therefore, this invention presents a a novel matter with large industrial application, namely the production of free ricin/RCA toxin castor-oil plants obtained through post-transcriptional silencing of ricin genes.

SUMMARY OF THE INVENTION

This invention relates to a method for obtaining ricin/RCA free castor-oil plants through the insertion of gene constructs into vegetable cells, particularly castor-oil plants, thus resulting in the production of ricin/RCA free castor-oil plant seeds.

A first embodiment of the invention provides synthetic polynucleotide molecules comprising a first region containing a nucleic acid sequence showing at least 90% similarity with the sequence described in SEQ ID. No. 12, and a second region containing the complement of the sequence from the first one.

An additional embodiment provides a synthetic polynucleotide comprising a first region containing a nucleic acid sequence as described in the SEQ. ID. No. 12, a second region containing a nucleic acid sequence as described in the SEQ. ID. No. 13 and a spacing region between the first and the second ones, containing a nucleic acid sequence as described in the SEQ. ID. No. 5.

This invention also provides a gene construct comprising a synthetic polynucleotide comprising a first region containing a nucleic acid sequence with at least 90% similarity with the sequence as described in the SEQ. ID. No. 12, and a second region containing the complement of the sequence from the first region, as well as a region of active gene promoter operationally bound to the synthetic polynucleotide. A vector containing said gene construct is also provided.

Additionally, this invention provides a vector comprising a gene promoter according to the sequence described in the SEQ. ID. No. 4, a first region encoding a nucleic acid sequence as described in the SEQ. Id. No. 12, a second region encoding a nucleic acid sequence according to the sequence described in the SEQ. ID. No. 13, a spacing region between the first and the second ones, containing a nucleic acid sequence as described in the SEQ. ID. No. 5, and end signal according to the sequence described in the SEQ. ID. No. 6, a marker gene comprising the promoter as described in the SEQ. ID. No. 7, a coding region as described in the SEQ. ID. No; 8 and an end signal as described in the SEQ. ID. No. 9, and a selection gene comprising the promoter as described in the SEQ. ID. No. 1, a coding region described in the SEQ. ID. No. 2, and an end signal described in the SEQ. ID. No. 3.

In another embodiment, the invention provides a double-helical filament molecule of ribonucleotide, produced by the expression of any of the previously mentioned nucleotide molecules.

This document also provides a method for obtaining ricin/RCA free castor-oil plants comprising the steps of:

-   -   a. inserting any of the aforesaid nucleic acid molecules into         castor-oil plant cells;     -   b. cultivating or regenerating the cells in specific means; and     -   c. selecting the plants with the silenced ricin gene.

This invention also provides an eukaryotic cell and plant comprising any of the aforesaid nucleic acid molecules. The plant seed is also provided.

Another embodiment refers to the method to the identification of the genetically modified plant, and comprises the steps of:

-   -   a. forming a mix comprising a biological sample containing         castor-oil plant DNA, and a pair of primers able to amplify a         specific nucleic acid from a genetically modified ricin/RCA free         castor-oil plant;     -   b. reacting to the mix under conditions that allow the pair of         nucleic acid primers to amplify a specific nucleic acid molecule         from a genetically modified ricin/RCA free castor-oil plant;     -   c. detecting the presence of a specific amplified nucleic acid         molecule from a genetically modified ricin/RCA free castor-oil         plant.

The invention also provides a kit to identify nucleic acid molecules of castor-oil plant from a biological sample comprising a pair of nucleic acid primers selected among the following pairs: SEQ ID NO 19 with SEQ ID NO 20, SEQ ID NO 21 with SEQ ID NO 22, SEQ ID NO 23 with SEQ ID NO 24 or SEQ ID NO 25 with SEQ ID NO 26.

This invention also provides a method for obtaining a ricin/RCA free castor-oil plant, comprising the steps of:

-   -   I. breeding a castor-oil plant containing a nucleic acid         molecule from the TB14S-5D event with a second castor-oil plant;     -   II. obtaining seeds from the breeding as described in the step         I;     -   III. obtaining a sample from the seed DNA, and     -   IV. detecting the presence of a nucleic acid molecule from the         event TB14S-5D of the castor-oil plant.

Finally, this invention provides castor oil extracted from transgenic seed, as well as the castor seed cake obtained by using transgenic seed.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1—A representation scheme of construct used to the transformation of the castor-oil plant. Vector for pRicRNAi biolistic composed by a transformation cassette, a fragment of ricin (ric) gene in sense and anti-sense interlayed by an intron, under the control of a promoter 35SCaMV and a terminator OCS, the ahas (AtAhas) gene and the gus gene driven by the promoter AtACT2.

FIG. 2—Gus expression in the event TB14S-5D from histochemical assay. Non-transgenic embryons do not show gus expression.

FIG. 3—The Southern blot assay shows the presence of transgenes representing Δricin (interference cassette) integrated inside the genome in two plants of the event TB14S-5D, while no signal is observed in non-transgenic plants (NT).

FIG. 4—Northern blot shows the presence of siRNAs (small RNAs) and the absence of ricin gene transcript in the event TB14S-5D (+). In contrast, no sRNA was observed, and the ricin gene transcript was present in NT plants, or negative segregants of the event TB14S-5D (−).

FIG. 5—Detection of ricin silencing in the event TB14S-5D. An ELISA test was performed to identify and quantify ricin in the endosperm of the event TB14S-5D seeds. Ricin was detected in the endosperm of non-transgenic seeds, as well as in the negative segregating seeds. However, ricin was not detected in positive seeds from the event TB14S-5D.

FIG. 6—The RCA120 silencing was observed in the hemagglutination assay. Seed proteins from the event TB14S-5D did not agglutinate red blood cells, as happened to the negative control (PBS) with the formation of a spot in the bottom of the plaque, while proteins of non-transgenic seeds (NT) agglutinated red blood cells, as happened to the positive control (RCA₁₂₀) with the formation of a diffuse bottom.

FIG. 7—PCR analysis showing the presence of fragments resulting from amplification of a fragment corresponding to a sequence of the interference cassette (Δricin). NT is a non-transgenic plant, and pRIcRNAi is the vector used in the gene modification of castor-oil plant.

FIG. 8—PCR analysis showing the presence of fragments resulting from the amplification of a fragment corresponding to the SEQ. ID. No. 27, a specific marker for the event TB14S-5D. 1—1 kb marker (Tools); 2 to 4—GM plants of the event TB14S-5D; 5—pRicRNAi; vector; 6—Control (non-transgenic plant).

FIG. 9: A representation scheme of the region amplified by primers AHASCD2F (SEQ ID NO 25) and SOJAE1R (SEQ ID NO 26), the sequence of which is described in the SEQ. ID. No. 27.

DETAILED DESCRIPTION OF THE INVENTION

This invention addresses the production of ricin/RCA toxin free castor-oil plants, obtained through the post-transcriptional ricin gene silencing.

Within the context of this specification, several terms used herein are defined as follows.

The term “nucleic acid” refers to a large molecule that can be either single or double stranded, composed of monomers (nucleotides) containing a sugar, a phosphate and a purine or pyrimidine base. A “nucleic acid fragment” is a fraction of a certain nucleic acid molecule. “Complementarity” refers to the specific pairing of purine and pyrimidine bases composed of nucleic acids: adenine and thymine pairs and guanine and cytosine pairs. So, the “complement” of a first nucleic acid fragment refers to the second nucleic acid fragment whose nucleotide sequence is complementary to the first nucleotide sequence.

In more developed plants, the deoxyribonucleic acid (DNA) is a gene material, while ribonucleic acid (RNA) is involved with information transfer from the DNA into proteins. A “genome” is the whole major portion of gene material contained in each cell of an organism. The term “nucleotide sequence” refers to nucleotide polymer sequences forming a DNA or RNA in a single or double strand, optionally synthetic, non-natural, or containing altered nucleotide bases with ability to incorporate inside DNA or RNA polymers. The term “oligomer” refers to short nucleotide sequences, usually up to 100 base-long. The term “homologous” refers to the bond between nucleotide sequences with two nucleic acid molecules, or between amino acid sequences with two protein molecules. An estimate of such homology is provided through hybridization of DNA-DNA or RNA-RNA under stringency conditions, as defined by the state of art (as mentioned in the document US20030074685, Hames and Higgins, Ed. (1985) Nucleic Acid Hybridization, IRL Press, Oxford, U.K); or by comparing the sequence similarity between two nucleic acid molecules or proteins (as mentioned in the document US20030074685, Needleman et al., J. Mol. Biol. (1970) 48:443-453).

“Gene” refers to the nucleotide fragment expressing a specific protein, including precedent (non-translated locus 5′) and posterior (non-translated locus 3′) regulatory sequences to the coding region. “Native gene” refers to a gene isolated from its own regulatory sequence found in the nature. “Chimeric gene” refers to the gene that comprises coding, regulatory and heterogeneous sequences not found in the nature. “Endogenous gene” refers to a native gene, usually found in its natural location inside the genome, that is not isolated. An “exogenous gene” refers to a gene that is not usually found in the host organism, being, instead, introduced there through gene transfer. “Pseudogene” refers to a nucleotide sequence that does not encode a functional enzyme.

“Coding sequence” refers to the DNA sequence that encodes a specific protein and excludes the non-coding sequence. An “interrupted coding sequence” means a sequence that acts as a separator (for instance, one or more introns binding through junctions).

An “intron” or “spacing region” is a nucleotide sequence transcript and present in the pre-mRNA, but that is removed through cleavage and re-connection of mRNA inside the cell, thus generating a mature mRNA that can be translated into a protein. Examples of introns include, but are not limited to pdk, pdk2 intron, castor bean catalase intron, delta 12 desaturase intron (cotton), delta 12 desaturase (Arabidopsis), maize ubiquitin intron, SV40 intron, ricin gene introns. This invention used the pdk intron (SEQ. ID. No. 5).

“RNA Transcript” refers to the product resulting from the catalyzed transcription of a DNA sequence by RNA polymerase. Whenever the RNA transcript is a perfect copy of the DNA sequence, it is referred to as primary transcript, or may be a RNA sequence derived from a post-transcriptional process of the primary transcript, being thus referred to as mature transcript. “Messenger RNA (mRNA)” refers to the RNA deprived of introns. “RNA sense” refers to a RNA transcript including mRNA. “RNA anti-sense” refers to a RNA transcript that is complementary to all the portions of a primary transcript or mRNA, and that is able to block a target gene expression through interfering in the process, transport and/or translation of its primary transcript or mRNA. The complementarity of a RNA anti-sense can be identified with any portion of the specific gene transcript, namely the non-translated sequence 5′, the non-translated sequence 3′, introns or coding sequence. Additionally, the RNA anti-sense may contain regions with ribozyme sequences that improve the effectiveness of RNA anti-sense to block the gene expression. “Ribozyme” refers to the catalyctic RNA and encompasses sequence-specific endoribonuclease. “DsRNA (double stranded RNA)” refers to the clip structure formed between the mRNA sequence or RNA sense, the sequence of a specing/intron region, and the RNA anti-sense sequence.

The term “similarity” refers to nucleic acid fragments where changes in one or more nucleotide bases do not affect the nucleic acid fragment's ability to mediate the alteration of the gene expression by gene silencing, such as, for instance, by using the anti-sense technology, the co-suppression or RNA interference (RNAi). Similar nucleic acid fragments herein can also be characterized by the percentage of similarity between their nucleotide sequences and the nucleotide sequences of nucleic acid fragments described herein (SEQ. ID. No. 12 and SEQ. ID. No. 13), as determined by ordinary algorithms employed by the state of art. The sequence alignment and the calculation of similarity percentage herein were performed by the DNAMAN Program for Windows (Lynnon Corporation, 2001), by using sequences filed in the Gene Bank through the Web browser integration. For this invention, it is possible to use other A channel regions with similar effect, as well as B channel sequences, but, in this latter case, with effect on RCA/RCA120 (Ricinus communis agglutinin).

The formation of dsRNA requires the presence, inside the DNA molecule, of a target gene nucleotide sequence in the sense orientation, and a nucleotide sequence in the anti-sense orientation, with or without a spacing/intron region between the sense and anti-sense nucleotide sequences. Said nucleotide sequences can be formed from about 19nt to 470 nt, or about 1740 nucleotides or more, provided that each one keeps a substantial similarity of total sequence from about 40% to 100%. The longer shall be the sequence, the lower shall be the stringency required to the total substantial similarity of the sequence. The fragments containing at least 19 nucleotides should preferably show about 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity of sequence, when compared to the reference sequence, with the possibility of containing about 2 different non-contiguous nucleotides. Fragment above 60 pb are preferably used, and still more preferably from 150 to 500 pb.

In one aspect of the invention, the dsRNA molecule may comprise one or more regions showing substantial sequence similarity for regions containing at least about 14 nucleotides consecutive to the target gene sense nucleotides defined as first region, and one or more regions showing substantial sequence similarity for regions containing about 15 nucleotides consecutive to the complement of target gene sense nucleotides, defined as second region, where such regions may present pairs of bases to separate them from each other. This invention used fragments of 461 nucleotides (SEQ. ID. No. 12 and SEQ. ID. No. 13) from the ricin gene of the castor-oil plant.

For convenience sake, the double stranded RNA (dsRNA) as described can be expressed in host cells, from a gene construct introduced and possibly integrated to the host cell's genome. So, in one embodiment, the invention refers to a synthetic polynucleotide comprising: a first region containing nucleic acid sequence showing at least 90, 95, 99 or 100% similarity with the sequence described in the SEQ. ID. No. 12, and a second region containing the complement of the sequence from the first region. Such polynucleotide may present a specing region between the first and the second ones; this spacing region may be an intron sequence selected among: pdk intron (SEQ. ID. No. 5), pdk2 intron, castor bean catalase intron, delta 12 desaturase intron (cotton), delta 12 desaturase (Arabidopsis), maize ubiquitin intron, SV40 intron, ricin gene introns.

“Promoter” refers to the DNA sequence in one gene, usually located upstream the coding sequence, that controls the coding sequence expression by promoting recognition by RNA polymerase and other factors required for the transcription itself. In the construct of an artificial DNA, promoters can also be used for the transcription of dsRNA. Promoters may also contain DNA sequences involved with binding protein factors that control the effect of the early transcription in response to physiological or development conditions.

In one of the embodiments, the invention provides a gene construct comprising the previously characterized polynucleotide and a region of the active gene promoter operationally bound to said polynucleotide.

Such promoter can be a promoter expressed in plants. As used herein, the term “promoter expressed in plants” means a DNA sequence that is able to start and/or control the transcription in a plant cell. This includes any vegetable promoter, any non-vegetable promoter that is able to direct the expression in a vegetable cell, such as, for instance, viral or bacterial promoters such as CaMV35S (as mentioned in the patent application patent US20030175783, Hapster et al, 1988 Mol. Gen. Genet. 212, 182-190) and gene promoters present in the T-DNA of Agrobacterium; tissue-specific or organ-specific promoters, including, but not limited to specific seed promoters (WO8903887), specific primary organs promoters (as mentioned in the patent application US20030175783, An et al., 1996 The Plant Cell 8, 15-30), stem-specific promoters (as mentioned in the patent application US20030175783, Keller et al., 1988 EMBO J. 7: 3625-3633), leave-specific promoters (as mentioned in the patent application US20030175783, Hudspeth et al., 1989 Plant Mol Biol 12:579-589), mesophyll-specific promoters, root-specific promoters (as mentioned in the patent application US20030175783, Keller et al., 1989 Genes Devel. 3:1639-1646), tuber-specific promoters (as mentioned in the patent application US20030175783, Keil et al., 1989 EMBO J. 8: 1323:1330), vascular tissue-specific promoters (as mentioned in the patent application US20030175783, Peleman et al., 1989 Gene 84: 359-369), stamen-specific promoters (WO8910396, WO9213956), dehiscence zone-specific promoters (WO9713865); and the like. This invention preferably used the following promoters: 1) Promoter of the Ahas gene from Arabidopsis thaliana that drives the ahas gene expression (pAtAhas—SEQ ID NO 1); 2) Constitutive promoter CaMV35S that drives the expression of K7 from RNAi to the ricin fragment (pCaMV35S—SEQ ID NO 4) and 3) Constitutive promoter of the Actin 2 gene from Arabidopsis thaliana that drives the gus gene expression (pAtAct2—SEQ ID NO 7).

The promoter may contain “enhancer” elements. An enhancer is a DNA sequence that can stimulate the promoter's activity. It can be an innate element from the promoter, or a heterologous element inserted to increase the level and/or the tissue-specificity of a promoter. This invention used the enhancer sequence of Alfalfa mosaic virus (35SCaMV).

“Constitutive promoters” refer to the ones that drive the gene expression in all the tissues and during the whole time. “Tissue-specific” or “development-specific” promoters are the ones that drive the gene expression almost exclusively in specific tissues, such as leaves, roots, stems, flowers, fruits, or seeds, or at specific development steps in a tissue, such as at the beginning and at the end of embryogenesis. The term “expression” refers to the transcription and stable accumulation of nucleic acid fragment-derived RNA of the invention that, together with the protein production structure of the cell results into altered levels of mio-inositol 1-phosphate synthase. “inhibition by interference” refers to the production of dsRNA transcripts that can prevent the target protein expression.

“Termination signal” or “terminators” are sequences that orientate the RNA polymerase enzyme to stop RNA transcription. The termination signal of transcription/terminators herein include, but are not limited to a SV40 termination signal, adenylation signal of HSV TK, termination signal of nopalyn synthetase from Agrobacterium tumefaciens (nos), termination signal of the gene RNA 35S from CaMV, termination signal of the virus that attacks Trifolium subterranean (SCSV), termination signal of the gene trpC from Aspergillus nidulans, and the like. This invention preferably used the following “termination signals” or “terminators”: 1) Terminator sequence of Ahas-3′ gene from Arabidopsis thaliana (SEQ ID NO 3); 2) Terminator sequence ocs-3′ that ends the expression of K7 from RNAi Ric (SEQ ID NO 6); and 3) Terminator sequence nos-3′ that ends the transcription of the gus reporter gene or uidA (SEQ ID NO 9).

“Appropriate regulatory sequences” refer to nucleotide sequences in native or chimeric genes, located above (non-translated region 5′), inside and/or below (non-translated region 3′) the nucleic acid fragments of the invention, that control the expression of nucleic acid fragments herein.

“Altered levels” refer to the production of gene products in transgenic organisms, in amounts or proportions that differ from the ones observed in normal or non-transgenic organisms. This invention also discloses vectors/gene constructs that include sequence fragments of ricin gene from the castor-oil plant in sense and anti-sense orientation, as well as host cells, that are genetically engineered with vectors of this invention. “Transformation” refers to the transfer of an exogenous gene into the genome of a host organism, and its genetically stable heritage.

Plants refer to photosynthetic and eucaroitic organisms. The nucleic acids of the invention can be used to provide desired traits basically in any plant. So, the invention can be used for several plant species, including the following genus: Anacardium, Anona, Arachis, Artocarpus, Asparagus, Atropa, Avena, Brassica, Carica, Citrus, Citrullus, Capsicum, Carthamus, Cocos, Coffee, Cucumis, Cucurbita, Daucus, Elaeis, Fragaria, Glycine, Gossypium, Helianthus, Heterocallis, Hordeum, Hyoseyamus, Lactuca, Linum, Lolium, Lupinus, Lycopersicon, Malus, Manihot, Majorana, Medicago, Nicotiana, Olea, Oryza, Panieum, Pannesetum, Passiflora, Persea, Phaseolus, Pistachia, Pisum, Pyrus, Prunus, Psidium, Raphanus, Ricinus, Secale, Senecio, Sinapis, Solanum, Sorghum, Theobromus, Trigonella, Triticum, Vicia, Vitis, Vigna, and Zea. Plants from the genus Ricinus were preferably used in this invention. More specifically, this invention refers to Ricinus communis plants.

Another object of this invention is to provide eukaryotic cells and eukaryotic organisms containing dsRNA of the invention, or gene constructs that are able to produce dsRNA of the invention. These gene constructs can be stably integrated in the genome of cells from eukaryotic organisms.

In another embodiment, the gene constructs can be provided in a DNA molecule that is able to replicate, on an autonomous basis, inside the cells of eukaryotic organisms, such as viral vectors. This invention used a sequence originated from the replication of Plasmidium from pKannibal (SEQ ID NO 10). The chimeric gene, or dsRNA can be also arranged on a transient basis inside the cells of eukaryotic organisms.

The gene constructs of this invention still present coding sequences for selection and marker genes to assist in the recovery process of the transgenic event. Several marker and selection genes can be used in this invention, including, but not limited to: nptll, hpt, neo, bar, ahas, epsps. This invention preferably used: 1) coding gene sequence of the Ahas gene from Arabidopsis thaliana (SEQ ID NO 2); 2) gus reporter gene sequence or uidA (SEQ ID NO 8); and 3) gene sequence of resistance to ampicillin from the plasmodium of pKannibal (SEQ ID NO 11).

An embodiment of the invention refers to a vector for plant transformation, comprising:

-   -   Gene promoter according to the sequence described in SEQ. ID.         No. 4;     -   A first coding region containing nucleic acid sequence according         to the sequence described in SEQ. ID. No. 12;     -   A second coding region containing nucleic acid sequence         according to the sequence described in SEQ. ID. No. 13;     -   A spacing region between the first and the second ones,         containing nucleic acid sequence according to the sequence         described in SEQ. ID. No. 5;     -   Termination signal according to the sequence described in SEQ.         ID. No. 6;     -   Marker gene comprising the promoter described in the SEQ. ID.         No. 7, a coding region described in the SEQ. ID. No. 8 and a         termination signal described in the SEQ. ID. No. 9;     -   Selection gene comprising the promoter described in the SEQ ID.         No. 1, an encoding region described in the SEQ. ID. No. 2, and a         termination signal described in the SEQ. ID. No. 3.

The polynucleotides, gene constructs and vectors of the invention can be introduced into the genome of a desired host plant through a variety of conventional techniques. For instance, they can be directly introduced into the genomic DNA of a vegetable cell by using techniques, such as electroporation and micro-injection of protoplasts of plant cells, or the construct can be directly introduced into a vegetable tissue, by using ballistic methods, such as bombing particles covered with DNA.

Micro-injection techniques are known from the state of art, being well described by the scientific and patent literature. The introduction of gene constructs by using glycol polyethylene precipitates is described by Paszkowski et al. Embo J. 3:2717-2722, 1984 (as mentioned in the patent application US20020152501). Electroporation techniques are described in From et al. Proc. Natl. Acad. Sci. USA 82:5824, 1985 (as mentioned in the patent application US20020152501). Ballistic transformation techniques are described in Klein et al. Nature 327:70-73, 1987 (as mentioned in the patent application US20020152501).

Alternatively, the gene constructs can be combined with flanking regions of appropriate T-DNA and introduced into a conventional vector inside the host Agrobacterium tumefaciens. The virulence of the host Agrobacterium tumefaciens shall drive the insertion of gene constructs and adjacent marker inside the DNA of the vegetable cell, as soon as the cell is infected by bacteria. Transformation techniques mediated by Agrobacterium tumefaciens, including disarming and the use of binary vectors are well described by the scientific literature (as mentioned in the patent application US 20020152501, Horsch et al. Science 233:496-498, 1984; and Fraley et al. Proc. Natl. Acad. Sci. USA 80:4803, 1983). This invention preferably used the biobalistic technique. Nevertheless, genetically modified castor-oil plants can be obtained from A. tumefaciens.

Transformed plant cells derived from any of the transformation techniques described above can be cultured to regenerate a whole plant transformed in its genotype, thus reaching the desired phenotype, such as lack or reduction in the seed mass. Such regeneration techniques rely upon the manipulation of certain phytohormones in tissue culture mean, typically containing a biocide and/or herbicide marker to be introduced together with the desired nucleotide sequence. Plant regeneration from a culture of protoplasts is described by Evans et al., Protoplasts Isolation and Culture, Handbook of Plant Cell Culture, pp. 124-176, MacMillilan Publishing Company, New York, 1983; and Binding, Regeneration of Plants, Plant Protoplasts, pp. 21-73, CRC Press, Boca Raton, 1985 (as mentioned in the patent application US20020152501). The regeneration can also be achieved through plant callus, explants, organs, or parts thereof. Such regeneration techniques are generally described in Klee et al., Ann. Ver. Of Plant Phys. 38:467-486, 1987 1985 (as mentioned in the patent application US20020152501).

Therefore, this invention refers to a method for obtaining ricin/RCA-free castor-oil plants, characterized by the fact that it comprises the steps of:

-   -   a. inserting into castor-oil plant cells the aforesaid nucleic         acid molecule, that can be a polynucleotide, a gene construct, a         vector or double filament ribonucleotide as previously defined;     -   b. culturing or regenerating castor-oil plant cells in specific         means;     -   c. selecting the castor-oil plants containing the silenced ricin         gene.

Without limiting the invention to a certain kind of action, the enzyme present in eukaryotic cells and responsible for generating small RNA molecules such as DICER in Drosophila is expected to be saturated through the inclusion of an exceeding amount of dsRNA sequences (double stranded RNA molecules), that are not related to the target gene nucleotide sequence, or to be gene to be silenced.

The natural variation in the posterior regulation of the target gene expression (that occurs between different lineages of eukaryotic organisms comprising the same dsRNA molecule) shall be replaced with the manipulation of the gene silencing spectrum. This result can be achieved through inclusion of nucleotide sequences of additional dsRNA non-related to the target gene, that are operationally bound to the dsRNA formed by the first and the second regions.

The invention also concerns the use of double filament ribonucleotide molecule of this invention to the suppression of ricin/RCA gene expression.

In another embodiment, the invention provides a method to identify transgenic free ricin/RCA castor-oil plants, comprising the steps of:

-   -   a. forming a mixture that comprises a biological sample         containing castor-oil plant DNA and a pair of primers able to         amplify a specific nucleic acid molecule from a genetically         modified ricin/RCA free castor-oil plant;     -   b. reacting to the mix under conditions that enable the pair of         nucleic acid primers to amplify a specific nucleic acid molecule         from a genetically modified ricin/RCA free castor-oil plant;     -   c. detecting the presence of the specific amplified nucleic acid         molecule from a genetically modified ricin/RCA free castor-oil         plant.

The primers used in the identification of the transgenic castor-oil plant are described in the table 1.

TABLE 1 pairs of primers used in the identification of genetically modified ricin/RCA free castor-oil plant: Function/target SEQ of the pair of ID Resulting primers Primer NO Sequence fragment Interference PSIUINTF 19 GAACCCAATTTCCCAACTG 798 pb cassette Δricin PSIUINTR 20 AGGTACCCCAATTGGTAAGGA Ricin gene RcRinR 21 GAAGCTTGGTACCTAATTCTCGTGCGCAT 460 pb sequence (A RcRinf 22 GTCTAGACTCGAGACATGAAATACCAGTGTTGC channel) Specific marker AHASCD2F 25 TATTCTTCCCAATCTCAGCC 396 pb of the event SOJAE1R 26 CCTCGGGATTTGATTTTTGGTCCT (SEQ ID TB14S-5D NO 27)

In another embodiment, the invention also comprises a kit for identification of a nucleic acid molecule of the event TB14S-5D from castor-oil plant in a biological sample comprising a pair of nucleic acid primers selected among the following pairs: SEQ ID NO 19 and SEQ ID NO 20, SEQ ID NO 21 and SEQ ID NO 22, SEQ ID NO 23 and SEQ ID NO 24 or SEQ ID NO 25 and SEQ ID NO 26, that are able to amplify a nucleic acid molecule from the event TB14S-5D of castor-oil plant, provided that this amplified molecule can be the sequence presented in SEQ. ID. No. 27.

This invention also provides a method for obtaining a ricin/RCA free castor-oil plant, characterized by the steps of:

-   -   1. breeding a castor-oil plant containing a nucleic acid         molecule of the event TB14S-5D and a second castor-oil plant;     -   2. obtaining seeds from the breeding described in the step (a);     -   3. obtaining a DNA sample of the seed; and     -   4. detecting the presence of nucleic acid molecule in the event         TB14S-5D of the castor-oil plant.

Finally, this invention provides castor oil extracted from transgenic seeds of transformed plants, comprising the nucleic acid molecules provided and the castor-oil plant cake obtained through a process that also uses such seeds.

The various experiments performed to check the presence/absence of ricin are described in the examples herein. While the endosperms of genetically modified seeds were used in the tests of hemagglutination and survival of epithelial cells of mouse gut (IEC-6), the embryonary axis (T1) were cultured in vitro, and then transferred into vegetation houses. Additionally, the GM plants presented a strong histochemical GUS activity, that made leaves, endosperms and embryonary axis notably blue within 20 minutes. The use of such marker shall be very useful to determine, even under field conditions, if a specific variety is genetically modified. This will be relevant to the safe use of GM varieties in animal nutrition, as the use of varieties containing ricin is lethal.

EXAMPLES

The full sequence of gene construct used herein is described in the SEQ. ID. No. 14, and any person skilled in the art shall be able to synthetize this sequence to insert it into the desired eukaryotic organism.

This invention is still defined in the following Examples. It must be clearly understood that these Examples, while indicating part of the invention, are only referred to for illustration purpose, and do not limit the scope herein.

Usual molecular biology techniques, such as bacterial transformation and electrophoresis in agarose gel of nucleic acids are referred to by ordinary terms used to describe them. Practical well-known details about these techniques are described by the state of art in Sambrook, et al. (Molecular Cloning, A Laboratory Manual, 2^(nd) ed. (1989), Cold Spring Harbor Laboratory Press). Several solutions used in experimental manipulations are referred to by their ordinary designations, such as “lysis solution”, “SSC”, “SDS”, etc. The compositions of such solutions can be found in the aforesaid reference Sambrook, et al.

Example 1 Building Vectors to the Gene Transformation of Castor-Oil Plants

The vector was built by using a RcRCAI gene fragment (SEQ ID NO 12,—sense and SEQ ID NO 13—anti-sense) that encodes the ricin A channel highly similar to RCA 120, as the A channel is responsible for the toxicity.

The whole DNA was isolated from fresh tissues of castor-oil plants by using the DNeasy Plant Mini Kit (Qiagen, Valencia, Calif., USA), and PCR reactions were performed to clone the RcRCAI gene by using the primers RcRINF (5′-GTCTAGACTCGAGACATGAAATACCAGTGTTGC-3′) and RcRINR (5′-GAAGCTTGGTACCTAATTCTCGTGCGCAT-3′) added with sites of Kpnl/Xhol and Hindlll/Xbal enzymes at the end of each one. The amplified fragment of about 480 pb was cloned in the vector pGEM-TEasy (Kobs, G. (1997) Cloning blunt-end DNA fragments into the pGEM®-T Vector Systems. Promega Notes 62, 15-18). Then, the intron-hairpin-type construct was performed through insertion of the fragment from RcRCAI gene in the sense (SEQ. ID. No. 12) and anti-sense (SEQ. ID. No. 12) orientations in the pKANNIBAL vector (Wesley, S., Helliwell, C., Smith, N., Wang, M., Rouse, D., Liu, Q., Gooding, P., Singh, S., Abbott, D., Stoutjesdijk, P., Robinson, S., Cleave, A., Green, A., and Waterhouse, P. 2001. Construct design for efficient, effective and high-throughput gene silencing in plants. Plant J. 27:581-590.) being separated by PDK intron (SEQ. ID. No. 5) under the promoter domain 35SCaMV (SEQ ID NO 4) and with the OCS terminator (SEQ. ID. No. 6), thus allowing the stranded RNA expression as source of generation of interfering RNAs. The transformation cassette (Promoter 35SKaMV—ricin fragment in the sense orientation—intron—ricin fragment in the anti-sense orientation—OCS terminator) was removed from pKANNIBAL vector in the site Nott, and inserted into the vector pAG1 (Aragão, F. J. L., Sarokin, L., Vianna, G. R., and Rech, E. L. 2000. Selection of transgenic meristematic cells utilizing a herbicidal molecule results in the recovery of fertile transgenic soybean (Glycine max (L.) Merrill) plants at high frequency. Theor. Appl. Genet. 101:1-6.) that contains the gus gene (β-Glucuronidase—uidA) as reporter gene and the ahas gene as selection gene, thus forming the vector/gene construct pRICRNAi. (FIG. 1, SEQ ID NO 14). The gus reporter gene expression (SEQ. ID. No. 8) is regulated, in this construct, by the constitutive promoter of Actin 2 gene from Arabidopsis thaliana (SEQ ID NO 7) and by the terminator nos-3′ (SEQ ID NO 9). On its turn, the ahas selection gene (SEQ ID NO 2) is regulated by the promoter of the Ahas gene from Arabidopsis thaliana and by the terminator of the Ahas-3′ gene from Arabidopsis thaliana (SEQ ID NO 3).

Example 2 Transformation of Castor-Oil Plants

The methodology for obtaining genetically modified lineages of castor-oil plants was developed from the bombing of particles in meristematic regions of zygotic embryons of castor-oil plants.

Healthy seeds from the cultivar EBDA-MPA-34 were selected and disinfected through washing in alcohol 70% for 1 minute, followed by washing at 2% sodium hypochlorite added with Tween 20 (20 μL for each 100 mL solution) for 20 minutes. The method described herein is not limited to the variety EBDA-MPA-34 (as other varieties can be used with similar results). The seeds were washed 4 times with distilled autoclaved water and were left soaking for 24 hours. Then, the see tegument was broken with pliers, and the zygotic embryons were removed with a clamp and left in water to avoid dehydration. The embryons were washed three times with distilled autoclavated water, disinfected in sodium hypochlorite 0.5% for 10 minutes, and washed five times with autoclaved distilled water; then, the water in excess was removed, and the embryons were placed in early induction mean containing MS (Murashige and Skoog basal medium—Sigma M5519) added with casein 300 mg L-1, thyamine 100 mg L-1, 3% sacarose, indol-butyric acid IBA 0.05 mg L-1, thidiazuron (TDZ) 0.5 mg·L-1, 1.4% agar and pH 4.0, where they stayed for 48 hours in the incubator at 28° C. in the dark.

Upon expiry of this period, the merysteme of embryons was exposed through removal of cotiledones and leaf primordia with a scalpel, and they were once more inserted into MII mean, for 24 hours before the transformation.

The zygotic embryons of castor-oil plant with exposed merysteme were placed in a bombing mean containing MS (Murashige and Skoog basal medium—Sigma M5519) 0.5× added with 3% sacarose, 0.8% phyragel and pH 5.8, so that the merysteme was placed upwards, and the gene transformation by biobalistic was performed according to Aragão et al. 2000 (Aragão, F. J. L., Sarokin, L., Vianna, G. R., and Rech, E. L. 2000. Selection of transgenic meristematic cells utilizing a herbicidal molecule results in the recovery of fertile transgenic soybean (Glycine max (L.) Merrill) plants at high frequency. Theor. Appl. Genet. 101:1-6).

According to histological and anatomic analysis of explants induced and cultured in culture means, before and after gene transformation to allow the view of cell layers from the zygotic embryon's apical merysteme under transformation process, competent cells for gene transformation and regeneration were introduced into specific culture means to the generation of other yolks, thus obtaining transgenic sprouts. The second inconvenient of the process was the in vitro rooting of transgenic sprouts that was induced, and thus allowed obtaining a whole GM plant from the transfer of transgenes to its descendants.

Therefore, after the transformation, the embryons were once more transferred into a MII mean where they stayed for 24 hours, and then transferred into the induction and selection mean MIS containing MS (Murashige and Skoog basal medium—Sigma M5519) added with inositol 100 mg·L⁻¹, casein 300 mg·L⁻¹, thyamine 100 mg·L⁻¹, sacarose 3%, AIB 0.05 mg·L⁻¹, TDZ 0.5 mg·L⁻¹, imazapyr 150 nM, agar 1.4% and pH 4.0, where they stayed for seven days. Upon expiry of this period, the explants were transferred into a maintenance mean of multi-sprout and selection (MMM) containing MS (Murashige and Skoog basal medium—Sigma M5519) added with inositol 100 mg·L⁻¹, casein 300 mg·L⁻¹, thyamine 100 mg·L⁻¹, sacarose 3%, AIB 0.1 mg·L⁻¹, zeatin 1 mg·L⁻¹, imazapyr 150 nM, agar 1.4% and pH 4.0 for 15 days. Upon expiry of this period, the sprouts were separated and transferred into a sprout stretching mean (MAB) containing MS (Murashige and Skoog basal medium—Sigma M5519) added with inositol 100 mg·L⁻¹, casein 300 mg·L⁻¹, thyamine 100 mg·L⁻¹, sacarose 3%, AIB 1 mg·L⁻¹, giberetic acid (GA3) 1 mg·L⁻¹, silver nitrate 5 μM, imazapyr 200 nM, agar 1.4% and pH 4.0 and kept under streaking at each 15-day period, until appearance of well structured and stretched explants of about 2-3 cm, that were transferred into a rooting mean containing MS (Murashige and Skoog basal medium—Sigma M5519) added with inositol 100 mg·L⁻¹, casein 300 mg·L⁻¹, thyamine 100 mg·L⁻¹, sacarose 3%, AIB 2 mg·L⁻¹, giberelic acid (GA3) 0.5 mg·L⁻¹, silver nitrate 5 μM, agar 1.4% and pH 4.0. Plantules with about 3-4 cm and roots were acclimatized in vegetation house, in 700 mL glasses containing soil and vermiculite (1:1) with a plastic bag to keep moisture. Once acclimatized, the plants were transferred into a 8 L pot containing soil.

Example 3 Regeneration of Castor-Oil Plants

After the transformation, the embryons were once more transferred into MII mean where they stayed for 24 hours, and then transferred into the induction and selection mean MIS containing MS (Murashige and Skoog basal medium—Sigma M5519) added with inositol 100 mg·L-1, casein 300 mg·L-1, thyamine 100 mg·L-1, sacarose 3%, AIB 0.05 mg·L-1, TDZ 0.5 mg·L-1, imazapyr 150 nM, agar 1.4% and pH 4.0 where they stayed for seven days. Upon expiry of this period, the explants were transferred into a maintenance mean of multi-sprout and selection containing MS (Murashige and Skoog basal medium—Sigma M5519) added with inositol 100 mg·L-1, casein 300 mg·L-1, thyamine 100 mg·L-1, sacarose 3%, AIB 0.1 mg·L-1, zeatin 1 mg·L-1, imazapyr 150 nM, agar 1.4% and pH 4.0 for 15 days. Upon expiry of the period, the sprouts were separated and transferred into a sprout stretching mean (MAB) containing MS (Murashige and Skoog basal medium—Sigma M5519) added with inositol 100 mg·L-1, casein 300 mg·L-1, thyamine 100 mg·L-1, sacarose 3%, AIB 1 mg·L-1, giberetic acid (GA3) 1 mg·L-1, silver nitrate 5 μM, imazapyr 200 nM, agar 1.4% and pH 4.0, and kept under streaking at each 15-day period, until appearance of well structured and stretched explants of about 2-3 cm, that were transferred into a rooting mean containing MS (Murashige and Skoog basal medium—Sigma M5519) added with inositol 100 mg·L-1, casein 300 mg·L-1, thyamine 100 mg·L-1, sacarose 3%, AIB 2 mg·L-1, giberetic acid (GA3) 0.5 mg·L-1, silver nitrate 5 μM, agar 1.4% and pH 4.0. Plantules with about 3-4 cm and roots were acclimatized in vegetation house, in 700 mL glasses containing soil and vermiculite (1:1) with a plastic bag to keep moisture. Once acclimatized, the plants were transferred into a 8 L pot containing red latosols.

Example 4 Identification of Genetically Modified Castor-Oil Plants by Gus Histochemical Assay

Tissues from the event TB14S-5D can be used in a histochemical assay to identify the event TB14S-5D from GUS protein expression in the x-gluc substrate according to Jefferson, R. A., Kavanagh, T. A. & Bevan, M. W. (GUS fusions: β-glucuronidase as a sensitive and versatile gene fusion marker in higher plants. EMBO J. 6, 3901-3907, 1987).

As shown by the FIG. 2, the transgenic plant construct presents GUS gene, while the GUS marker was not expressed in the control plant.

Example 5 Identification of Genetically Modified Castor-Oil Plants by Southern Blot

It is possible to detect the event TB14S-5D by fixing the whole DNA of the event TB14S-5D in a membrane, and by hybridizing with a homologous probe the region Δricin corresponding to the region amplified with primers PSIUINTF (SEQ ID NO 19) and PSIUINTR (SEQ ID NO 20). Methodology according to [Lacorte, C., Vianna, G., Aragão, F. J. L. & Rech, E. L. Molecular Characterization of Genetically Manipulated Plants in Plant Cell Culture: Essential Methods (ed. Davey, M. R. & Anthony, P.) 261-279 (John Wiley & Sons, 2010)].

The FIG. 3 shows the results from Southern blot for the identification of transgenic events.

Example 6 Identification of Genetically Modified Castor-Oil Plants by Northern Blot Analysis

The analysis of RNAi from T1 seed endosperms allowed the identification of mRNAs of Ricin/RCA inside non-GM plants, as well as the identification of siRNAs in the endosperms of genetically modified T1 seeds.

Ricin silencing was detected in the event TB14S-5D by isolating the RNA and by hybridizing with a homologous probe the ricin region corresponding to the amplified 148 pb fragment by employing the pair of primers Ric149RNAiF (SEQ ID NO 23)/RcRinf: (SEQ ID NO 24). The methodology was implemented according to Aragão, F. J. L., Nogueira, E. O. P. L., Tinoco, M. L. P. & Faria, J. C. Molecular characterization of the first commercial transgenic common bean immune to the Bean golden mosaic virus. J. Biotechnol. 166, 42-50; 10.1016/j.jbiotec.2013.04.009, 2013).

The FIG. 4 shows the transgenic plants of the event identified by Northern blot.

Example 7 Identification of Genetically Modified Castor-Oil Plants by ELISA

It is possible to detect the ricin silencing in the event TB14S-5D by extracting whole proteins and by quantifying the amount of ricin in mature seeds of the event TB14S-5D by ELISA (Enzyme-Linked Immunosorbent Assay) de acordo com (Baldoni, A. B., Araújo, A. C. G., Carvalho, M. H., Gomes, A. C. M. M. & Aragão, F. J. L. Immunolocalization of ricin accumulation during castor bean (Ricinus communis L.) seed development. Int. J. Plant Biol. 1: and 12, 61-65, 2010).

ELISA was used to detect and quantify the amount of ricin in segregating seeds from the transgenic lineage TB14S-5D. As shown by the results, the wild-type (Non-GM) seeds presented 20 ng ricin/μg of whole protein, while the segregating seeds (that do not contain transgenes) presented statistically similar amounts of ricin, when compared to the control (non-transgenic plants). In contrast, ricin was not detectable by ELISA in transgenic seeds. Considering the cross-reaction between the antibody produced against ricin A channel and RCA120 due to their high identity, our results indicated that both ricin and RCA120 were silenced.

FIG. 5 shows the detection of ricin silencing in the event TB14S-5D. Ricin was detected in the endosperm of non-transgenic seeds and in the negative segregating seeds. Nevertheless, no ricin was detected in positive seeds from the event TB14S-5D.

Example 8 Hemagglutination Assay

RCA120 silencing in the event TB14S-5D was detected by red blood cell hemagglutination assay, through extraction of whole proteins of the event TB14S-5D and addition into blood solution under serial dilution, where the non-hemagglutination of red blood cells was observed.

Ricin is a lectin that has been described as weak hemagglutinine, while RCA120 presents a strong hemagglutinating activity. So, we performed an hemagglutination test with whole proteins isolated from the endosperm of both transgenic and non-transgenic castor-oil seeds. Strong hemagglutination was observed when isolated proteins of non-transgenic seeds were used at the 2.5 μg/μL concentration of whole protein, and even the 19 ng/μL concentration of whole protein was evident. In contrast, no hemagglutination activity was detected with proteins isolated from transgenic seeds, not even at the highest protein concentration (about 131-fold more concentrated). Moreover, the agglutination activity was not observed in ox blood cells incubated with PBS (white), while the purified RCA120 presented strong hemagglutinating activity event at a 0.39 ng/μL concentration. In addition to the absence of transcripts, the ricin and RCA120 proteins were not detected in the endosperms of T1 seeds from the TB14S-5D, thus confirming the efficient Ricin and RCA120 silencing.

FIG. 6 shows the result from a hemagglutination assay performed with proteins from seeds of the event TB14S-5D and with control group: the proteins from seeds of the event TB14S-5D did not agglutinate red blood cells as happened to the negative control (PBS) with the formation of a spot on the bottom of the plaque, while proteins from non-transgenic seeds agglutinated red blood cells as happened to the positive control (RCA120), with the formation of a diffuse bottom.

Example 9 Identification of Genetically Modified Castor-Oil Plants by PCR

It is possible to detect the event TB14S-5D by PCR by using the pairs of primers PSIUINTF (SEQ ID NO 19) with PSIUINTR (SEQ ID NO 20) and AHASCD2F (SEQ ID NO 25) with SOJAE1R (SEQ ID NO 26). Methodology implemented according to Lacorte, C., Vianna, G., Aragão, F. J. L. & Rech, E. L. Molecular Characterization of Genetically Manipulated Plants in Plant Cell Culture: Essential Methods (ed. Davey, M. R. & Anthony, P.) 261-279 (John Wiley & Sons, 2010). The FIG. 9 presents a scheme showing the region amplified by the primers AHASCD2F and SOJAE1R.

The FIGS. 7 and 8 show that the transgenic plants of the event were detected by the relevant primers. In the FIG. 8, it is possible to identify the presence of 396 pb strand referring to the SEQ. ID. No. 27, that is a specific marker to the event TB14S-5D.

Example 10 Cell Feasibility Study

Epithelial cells from mouse gut (IEC-6) were incubated for 24 hours with total proteins isolated from endosperm of both transgenic and non-transgenic seeds. The feasibility of the cells exposed to proteins isolated from non-GM plants containing 1 or 10 ng ricin/mL was reduced to 53% and 16% respectively. Nevertheless, cells exposed to the corresponding amount of proteins from transgenic seed kept their feasibility at 97% (at 0.5 μg total protein/mL) and at 78% at the highest protein concentration (50 μg total protein/mL). There was no statistic difference between the feasibility percentages of 97% and 78%, and such results were corroborated by the fact that the protein synthesis was inhibited within a range from 40% to 90% in cells cultured for 5 hours with proteins from non-transgenic seeds containing 0.1 and 1 ng ricin/mL respectively. Nevertheless, no inhibition was observed in cells cultured in the presence of the corresponding amount of proteins isolated from transgenic seeds, not even at the highest total protein concentration. Accordingly, we demonstrated that the seeds from GM plants were not toxic to the culture of epithelial cells from mouse gut.

Example 11 Cell Survival Test

Mice (Swiss Webster) were treated by intraperitoneal administration with endosperm from castor-oil plant seeds to the measurement of ricin in the lethal challenge test. We performed the ricin challenge by injecting into mice whole proteins isolated from the event TB14S-5D, as well as from non-transgenic seeds. As expected, all the animals that underwent the intraperitoneal injection with 20 μg wild-type see proteins/g of body weight (552 μg ricin/kg of body weight) died within the first 24-hour period. Nevertheless, animals injected with the corresponding amounts of whole proteins isolated from seeds of the event TB14S-5D survived without visible symptoms of intoxication by ricin (diarrhea, weakness, loss of appetite, black stools, and loss of weight). As a matter of fact, a remarkably reduced glycaemia level was observed among animals injected with proteins from non-transgenic seeds. Nevertheless, there was no significant alteration in the glycaemia of animals injected with proteins from transgenic seeds for a 60 hour-period. The animals were monitored for an additional 7-day period, and no death was recorded in the group of mice injected with proteins from the event TB14S-5D. In the in vivo toxicity test with whole proteins isolated from seeds of the event TB14S-5D, not even an amount 15 to 230-fold of amounts of DL50 presented toxic effects for mice. According to these results, we estimated that mice could consume GM castor bean cake in an amount up to 52% of their body weight without presenting acute intoxication. Generally, the daily consumption of protein sources by cows, sheeps and goats only represents 1 to 2% of their body weight. 

1. Synthetic polynucleotide characterized by the fact that it comprises: A) A first region containing nucleic acid sequences with at least 90% similarity with the sequence described in the SEQ. ID. No. 12; B) A second region containing the complement of the sequence described in (A);
 2. Polynucleotide according to the claim 1, characterized by the fact that the nucleic acid sequences from (A) present at least 95% similarity with the sequence described in the SEQ. ID. No.
 12. 3. Polynucleotide according to the claim 2, characterized by the fact that the nucleic acid sequence from (A) presents at least 99% similarity with the sequence described in the SEQ. ID. No.
 12. 4. Polynucleotide according to the claim 3, characterized by the fact that the nucleic acid sequence from (A) presents a sequence as described in the SEQ. Id. No.
 12. 5. Polynucleotide according to claim 1, characterized by the fact that the first and the second regions can produce a double-stranded RNA molecule.
 6. Polynucleotide according to the claim 5, characterized by the fact that it presents a spacing region between the first and the second ones.
 7. Polynucleotide according to the claim 6, characterized by the fact that the spacing sequence is an intron.
 8. Polynucleotide according to the claim 7, characterized by the fact that the intron is selected from a group formed by: pdk, pdk2 intron, castor bean catalase intron, delta 12 desaturase intron (cotton), delta 12 desaturase (Arabidopsis), maize ubiquitin intron, SV40 intron, and ricin gene introns.
 9. Polynucleotide according to the claim 8, characterized by the fact that the spacing region is the pdk intron.
 10. Synthetic polynucleotide characterized by the fact that it comprises: a) A first region containing nucleic acid sequence according to the sequence as described in the SEQ. ID. No. 12; b) A second region containing nucleic acid sequence according to the sequence as described in the SEQ. ID. No. 13; c) A spacing region between the first and the second regions, containing nucleic acid sequence according to the sequence as described in the SEQ. Id. No.
 5. 11. Gene construct characterized by the fact that it comprises: i) a polynucleotide according to claim 1; ii) a region of active promoter gene operationally bound to the polynucleotide defined in (i).
 12. Gene construct according to the claim 11, characterized by the fact that the promoter gene from (ii) presents nucleic acid sequence according to the sequence as described in the SEQ. ID. No.
 4. 13. Vector to the plant transformation, characterized by the fact that it comprises a gene construct according to the claim
 11. 14. Vector to the plant transformation, characterized by the fact that it comprises: A promoter gene according to the sequence described in the SEQ. ID. No. 4; A first coding region containing nucleic acid sequence according to the sequence as described in the SEQ. ID. No. 12; A second coding region containing nucleic acid sequences according to the sequence as described in the SEQ. ID. No. 13; A specing region between the first and the second regions, containing nucleic acid sequence according to the sequence as described in the SEQ. ID. No. 5; A termination signal according to the sequence as described in the SEQ. ID. No. 6; A marker gene comprising the promoter described in the SEQ. ID. No. 7, a coding region described in the SEQ. ID. No. 8, and a termination signal as described in the SEQ. ID. No. 9; A selection gene comprising the promoter as described in the SEQ. ID. No. 1, a coding region as described in the SEQ. ID. No. 2 and a termination signal as described in the SEQ. ID. No.
 3. 15. A double-filament ribonucleotide molecule characterized by the fact that it is produced from the expression of a nucleic acid molecule according to claim
 1. 16. Use of the molecule described in the claim 15, characterized by the fact that it results into the suppression of ricin/RCA gene expression.
 17. Method for obtaining ricin/RCA-free castor-oil plants, characterized by the fact that it comprises the steps of: I) inserting into casteukaryoor-oil plant cells a nucleic acid molecule according to claim 1; II) culturing or regenerating the cells in specific means; III) selecting the plants containing the silenced ricin gene.
 18. Eukaryotic cell characterized by the fact that it comprises a nucleotide molecule according to claim
 1. 19. Eukaryotic cell according to the claim 18, characterized by the fact that it is a Ricinus communis cell.
 20. Transformed plant characterized by the fact that it comprises a nucleotide molecule defined in claim
 1. 21. Plant according to the claim 20 characterized by the fact that it is a Ricinus communis plant.
 22. Plant according to the claim 21 characterized by the fact that it is an event TB14S-5D.
 23. Transgenic seed or propagative part thereof, characterized by the fact that it is a plant according to the claim
 20. 24. Method to the identification of a genetically transformed plant, characterized by the fact that it comprises the steps of: A. forming a mix comprising a biological sample containing castor-oil plant DNA, and a pair of primers able to amplify a specific nucleic acid from a genetically modified ricin/RCA free castor-oil plant; B. reacting to the mix under conditions that allow the pair of nucleic acid primers to amplify a specific nucleic acid molecule from a genetically modified ricin/RCA free castor-oil plant; C. detecting the presence of a specific amplified nucleic acid molecule from a genetically modified ricin/RCA free castor-oil plant.
 25. Method according to the claim 24 characterized by the fact that the genetically modified ricin/RCA free castor-oil plant is the event TB14S-5D.
 26. Method according to the claim 24 characterized by the fact that the pair of primers is selected among the following pairs: SEQ ID NO 19 and SEQ ID NO 20, SEQ ID NO 21 and SEQ ID NO 22 or SEQ ID NO 23, SEQ ID NO 24 or SEQ ID NO 25 and SEQ ID NO
 26. 27. Method according to the claim 26 characterized by the fact that the pair of primers is: SEQ ID NO 25 and SEQ ID NO
 26. 28. Method according to the claim 24 characterized by the fact that the B step amplifies a specific nucleic acid molecule according to the sequence as described in the SEQ. ID. No.
 27. 29. Kit to the identification of a nucleic acid molecule from castor-oil plant in a biological sample able to amplify a nucleic acid molecule of the event TB14S-5D, characterized by the fact that it comprises a pair of nucleic acid primers selected among the following: SEQ ID NO 19 and SEQ ID NO 20, SEQ ID NO 21 and SEQ ID NO 22, SEQ ID NO 23 and SEQ ID NO 24 or SEQ ID NO 25 and SEQ ID NO
 26. 30. Identification kit according to the claim 29, characterized by the fact that it comprises the pair of nucleic acid primers SEQ ID NO 25 and SEQ ID NO
 26. 31. Kit to the identification of a nucleic acid molecule from castor-oil plant in a biological sample characterized by the fact that it amplifies the sequence described in the SEQ. ID. No.
 27. 32. Method for obtaining ricin/RCA-free castor-oil plants, characterized by the fact that it comprises the steps of: I. breeding a castor-oil plant containing a nucleic acid molecule from the TB14S-5D event with a second castor-oil plant; II. obtaining seeds from the breeding as described in the step I; III. obtaining DNA samples from the seeds; and IV. detecting the presence of a nucleic acid molecule from the event TB14S-5D of the castor-oil plant.
 33. Method for obtaining a ricin/RCA-free castor-oil plant according to the claim 32 characterized by the fact that the step IV detects the presence of a nucleic acid molecule as described in the SEQ. ID. No.
 27. 34. Castor oil characterized by the fact that it is extracted from a transgenic seed comprising a nucleotidic molecule according to claim
 1. 35. Castor seed cake characterized by the fact that it is obtained through a process that uses transgenic seeds comprising a nucleotidic molecule according to claim
 1. 